Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
481 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019
482 Pediatric Osteosarcoma of Extremities: a 15-year Experience from a Tertiary Care Cancer Center in Upper Egypt Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2019
483 Assesment OF complement regulatory protients CD55 and CD59 on erythocytes in Betathalassemia major patients Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
484 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Medical Oncology Nehal Adel Rayan Mohammed 2019
485 Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2019
486 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Surgical Oncology Dr. Ali Zedan Tohamy mohammed 2019
487 Complication versus Radicality in Papillary Thyroid Cancer Surgery: How to Keep the Balance? Department of Radiology Dr. Haisam Ahmed Samy Aly Atta 2019
488 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Clinical Pathology Asmaa Ahmed Mohamed ahmed 2019
489 The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
 		Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2019
490 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2019